Health e News
Results from the first ever microbocide trial to go through all phases of research are due to be released early next year. A microbicide is a substance that can be inserted vaginally or anally with the aim of protecting its users from HIV infection.
As the international community is focusing on HIV/AIDS, malaria and tuberculosis another rapidly growing epidemic, diabetes, is also demanding attention.
Improved diagnostics, new medicines for drug resistant TB, the integration of HIV and TB treatment, increased funding and political will are some of the resources needed for a stronger effort against Tuberculosis.
The French humanitarian agency, Doctors Without Borders (MSF), has called for a new approach in dealing with patients with Multi-Drug Resistant Tuberculosis.
Activists have called for global action to stem the tide of deaths attributed to tuberculosis.
Clinic fails to test her for TB, Brooklyn refuses to admit her and doctor advises an abortion but Busi Beko and her daughter survive MDR TB.
Tuberculosis (TB) and its drug resistant strain is out of control in Zimbabwe, advocacy organisations in the country have warned.
The world is in desperate need of better medicines to deal both with the increase in multi-drug resistant TB and the problem of the co-infection of TB and HIV, say experts.
Health experts say the high level of tobacco use among South African children of school going age is worrisome.
Health systems cannot properly diagnose, treat, or contain the co-epidemic of HIV and tuberculosis (TB) because not enough is known about how the two diseases interact.
South Africa’€™s health department has come under fire from activists and HIV/tuberculosis experts for its failure to respond to extensively drug resistant (XDR) TB with claims that one of the critical drugs to stem this epidemic is not available in KwaZulu-Natal, the hotbed of the outbreak.
Differences between government and AIDS activists are slowing down efforts to reach agreement on a comprehensive plan for HIV and AIDS in prisons.
